Adjuvant Radiotherapy in Breast Cancer: A Comparison of Two Accelerated Hypofractionated Protocols
SECI Oncology · 2013
DOI: 10.18056/seci2013.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift SECI Oncology, 2013. Verfasst von Ahmad Shehata.
Abstract (Originalsprache)
Introduction Conventional radiotherapy after breast surgery requires 5-7 weeks of daily treatment [1,2]. Such a long treatment schedule has major implications on both patient quality of life and radiotherapy departments, as a high number of breast cancer patients receive radiotherapy. A shorter breast radiotherapy schedule would be more convenient for patients (especially those coming from remote areas to radiotherapy facilities) and for health care providers, as it would increase the turnover in radiotherapy departments. Accelerated hypofractionated approach is based on the radiobiologic model that a lower total dose delivered in fewer, larger fractions over a shorter period of time is at least as effective as the traditional longer schedule[3]. Increasing evidence from randomized trials comparing conventional radiotherapy schedules to different hypofractionated ones in whole breast irradiation after conserving surgery show that breast adenocarcinoma may be associated with lower α/β ratio than previously thought and closer to those of late-reacting healthy tissues [3-7]. The LQ model suggests that, when the α/β ratio for the tumor is similar to that of the surrounding lateresponding normal tissue, the hypofractionated regimen may be equally or potentially more effective than the conventional one [8]. Accelerated hypofractionation using 4240 cGy in 16 fractions given in 3 weeks. This is accepted as a fairly standard dosage world over and at our institute. It is very well tolerated and its toxicity is comparable to the five weeks protocol [5]. In the published UK Start Trial A, women assigned after primary surgery to receive 50 Gy in 25 fractions of 2.0 Gy or 41.6 Gy in 13 fractions of 3.2 Gy or 39 Gy in 13 fractions of 3.0 Gy and results revealed comparable efficacy and toxicities [4]. The aim of this study is to compare the efficacy and toxicities of two different protocols of accelerated hypofractionated radiotherapy in breast cancer patients treated as adjuvant setting.
Zitieren
APA
Shehata, A. (2013). Adjuvant Radiotherapy in Breast Cancer: A Comparison of Two Accelerated Hypofractionated Protocols. SECI Oncology. https://doi.org/10.18056/seci2013.1
Vancouver
Shehata A. Adjuvant Radiotherapy in Breast Cancer: A Comparison of Two Accelerated Hypofractionated Protocols. SECI Oncology. 2013. doi:10.18056/seci2013.1
BibTeX
@article{Shehata2013,
author = {Shehata, Ahmad},
title = {Adjuvant Radiotherapy in Breast Cancer: A Comparison of Two Accelerated Hypofractionated Protocols},
journal = {SECI Oncology},
year = {2013},
doi = {10.18056/seci2013.1}
}
EUVIMED